La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Molecular changes in the postmortem parkinsonian brain.

Identifieur interne : 000230 ( Main/Exploration ); précédent : 000229; suivant : 000231

Molecular changes in the postmortem parkinsonian brain.

Auteurs : Damien Toulorge [France] ; Anthony H V. Schapira [Royaume-Uni] ; Rodolphe Hajj [France]

Source :

RBID : pubmed:27381749

Abstract

Parkinson disease (PD) is the second most common neurodegenerative disease after Alzheimer disease. Although PD has a relatively narrow clinical phenotype, it has become clear that its etiological basis is broad. Post-mortem brain analysis, despite its limitations, has provided invaluable insights into relevant pathogenic pathways including mitochondrial dysfunction, oxidative stress and protein homeostasis dysregulation. Identification of the genetic causes of PD followed the discovery of these abnormalities, and reinforced the importance of the biochemical defects identified post-mortem. Recent genetic studies have highlighted the mitochondrial and lysosomal areas of cell function as particularly significant in mediating the neurodegeneration of PD. Thus the careful analysis of post-mortem PD brain biochemistry remains a crucial component of research, and one that offers considerable opportunity to pursue etiological factors either by 'reverse biochemistry' i.e. from defective pathway to mutant gene, or by the complex interplay between pathways e.g. mitochondrial turnover by lysosomes. In this review we have documented the spectrum of biochemical defects identified in PD post-mortem brain and explored their relevance to metabolic pathways involved in neurodegeneration. We have highlighted the complex interactions between these pathways and the gene mutations causing or increasing risk for PD. These pathways are becoming a focus for the development of disease modifying therapies for PD. Parkinson's is accompanied by multiple changes in the brain that are responsible for the progression of the disease. We describe here the molecular alterations occurring in postmortem brains and classify them as: Neurotransmitters and neurotrophic factors; Lewy bodies and Parkinson's-linked genes; Transition metals, calcium and calcium-binding proteins; Inflammation; Mitochondrial abnormalities and oxidative stress; Abnormal protein removal and degradation; Apoptosis and transduction pathways. This article is part of a special issue on Parkinson disease.

DOI: 10.1111/jnc.13696
PubMed: 27381749


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Molecular changes in the postmortem parkinsonian brain.</title>
<author>
<name sortKey="Toulorge, Damien" sort="Toulorge, Damien" uniqKey="Toulorge D" first="Damien" last="Toulorge">Damien Toulorge</name>
<affiliation wicri:level="1">
<nlm:affiliation>Encefa, Le Kremlin Bicêtre, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Encefa, Le Kremlin Bicêtre</wicri:regionArea>
<wicri:noRegion>Le Kremlin Bicêtre</wicri:noRegion>
<wicri:noRegion>Le Kremlin Bicêtre</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Schapira, Anthony H V" sort="Schapira, Anthony H V" uniqKey="Schapira A" first="Anthony H V" last="Schapira">Anthony H V. Schapira</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Clinical Neuroscience, UCL Institute of Neurology, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hajj, Rodolphe" sort="Hajj, Rodolphe" uniqKey="Hajj R" first="Rodolphe" last="Hajj">Rodolphe Hajj</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Discovery, Pharnext, Issy-Les-Moulineaux, France. rhajj@pharnext.com.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Discovery, Pharnext, Issy-Les-Moulineaux</wicri:regionArea>
<wicri:noRegion>Issy-Les-Moulineaux</wicri:noRegion>
<wicri:noRegion>Issy-Les-Moulineaux</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27381749</idno>
<idno type="pmid">27381749</idno>
<idno type="doi">10.1111/jnc.13696</idno>
<idno type="wicri:Area/PubMed/Corpus">000077</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000077</idno>
<idno type="wicri:Area/PubMed/Curation">000077</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000077</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000077</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000077</idno>
<idno type="wicri:Area/Ncbi/Merge">001A65</idno>
<idno type="wicri:Area/Ncbi/Curation">001A65</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001A65</idno>
<idno type="wicri:Area/Main/Merge">000232</idno>
<idno type="wicri:Area/Main/Curation">000230</idno>
<idno type="wicri:Area/Main/Exploration">000230</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Molecular changes in the postmortem parkinsonian brain.</title>
<author>
<name sortKey="Toulorge, Damien" sort="Toulorge, Damien" uniqKey="Toulorge D" first="Damien" last="Toulorge">Damien Toulorge</name>
<affiliation wicri:level="1">
<nlm:affiliation>Encefa, Le Kremlin Bicêtre, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Encefa, Le Kremlin Bicêtre</wicri:regionArea>
<wicri:noRegion>Le Kremlin Bicêtre</wicri:noRegion>
<wicri:noRegion>Le Kremlin Bicêtre</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Schapira, Anthony H V" sort="Schapira, Anthony H V" uniqKey="Schapira A" first="Anthony H V" last="Schapira">Anthony H V. Schapira</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Clinical Neuroscience, UCL Institute of Neurology, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hajj, Rodolphe" sort="Hajj, Rodolphe" uniqKey="Hajj R" first="Rodolphe" last="Hajj">Rodolphe Hajj</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Discovery, Pharnext, Issy-Les-Moulineaux, France. rhajj@pharnext.com.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Discovery, Pharnext, Issy-Les-Moulineaux</wicri:regionArea>
<wicri:noRegion>Issy-Les-Moulineaux</wicri:noRegion>
<wicri:noRegion>Issy-Les-Moulineaux</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of neurochemistry</title>
<idno type="eISSN">1471-4159</idno>
<imprint>
<date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Parkinson disease (PD) is the second most common neurodegenerative disease after Alzheimer disease. Although PD has a relatively narrow clinical phenotype, it has become clear that its etiological basis is broad. Post-mortem brain analysis, despite its limitations, has provided invaluable insights into relevant pathogenic pathways including mitochondrial dysfunction, oxidative stress and protein homeostasis dysregulation. Identification of the genetic causes of PD followed the discovery of these abnormalities, and reinforced the importance of the biochemical defects identified post-mortem. Recent genetic studies have highlighted the mitochondrial and lysosomal areas of cell function as particularly significant in mediating the neurodegeneration of PD. Thus the careful analysis of post-mortem PD brain biochemistry remains a crucial component of research, and one that offers considerable opportunity to pursue etiological factors either by 'reverse biochemistry' i.e. from defective pathway to mutant gene, or by the complex interplay between pathways e.g. mitochondrial turnover by lysosomes. In this review we have documented the spectrum of biochemical defects identified in PD post-mortem brain and explored their relevance to metabolic pathways involved in neurodegeneration. We have highlighted the complex interactions between these pathways and the gene mutations causing or increasing risk for PD. These pathways are becoming a focus for the development of disease modifying therapies for PD. Parkinson's is accompanied by multiple changes in the brain that are responsible for the progression of the disease. We describe here the molecular alterations occurring in postmortem brains and classify them as: Neurotransmitters and neurotrophic factors; Lewy bodies and Parkinson's-linked genes; Transition metals, calcium and calcium-binding proteins; Inflammation; Mitochondrial abnormalities and oxidative stress; Abnormal protein removal and degradation; Apoptosis and transduction pathways. This article is part of a special issue on Parkinson disease.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
<li>Royaume-Uni</li>
</country>
<region>
<li>Angleterre</li>
<li>Grand Londres</li>
</region>
<settlement>
<li>Londres</li>
</settlement>
</list>
<tree>
<country name="France">
<noRegion>
<name sortKey="Toulorge, Damien" sort="Toulorge, Damien" uniqKey="Toulorge D" first="Damien" last="Toulorge">Damien Toulorge</name>
</noRegion>
<name sortKey="Hajj, Rodolphe" sort="Hajj, Rodolphe" uniqKey="Hajj R" first="Rodolphe" last="Hajj">Rodolphe Hajj</name>
</country>
<country name="Royaume-Uni">
<region name="Angleterre">
<name sortKey="Schapira, Anthony H V" sort="Schapira, Anthony H V" uniqKey="Schapira A" first="Anthony H V" last="Schapira">Anthony H V. Schapira</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000230 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000230 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:27381749
   |texte=   Molecular changes in the postmortem parkinsonian brain.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:27381749" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonFranceV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024